Daiken Biomedical Co (TPE:7780) Total Equity: NT$5,443 Mil (As of Dec. 2025)


TPE:7780 Daiken Biomedical Co Ltd TPE:7780
23 GF Score
Price NT$18.35
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co Total Equity?

Daiken Biomedical Co TPE:7780 +1.66% 23 Total Equity is NT$5,443 Mil as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

Daiken Biomedical Co's total equity for the quarter that ended in Dec. 2025 was NT$5,443 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Daiken Biomedical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiken Biomedical Co Total Equity Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
227.43 247.32 1,306.99 5,442.70

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,306.99 1,217.42 1,107.43 5,348.51 5,442.70
TPE:7780
23GF Score
Daiken Biomedical Co Ltd TPE:7780
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Daiken Biomedical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5912.651-469.947
=5,443

Daiken Biomedical Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5912.651-469.947
=5,443

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$5,443 Mil mean?
Daiken Biomedical Co (TPE:7780) has a Total Equity of NT$5,443 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Daiken Biomedical Co and its competitors.
Is Daiken Biomedical Co's Total Equity too high?
Daiken Biomedical Co's current Total Equity is NT$5,443 Mil. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Total Equity compare to KHC and GIS?
Daiken Biomedical Co's Total Equity of NT$5,443 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current Total Equity is NT$5,443 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Total Equity of NT$5,443 Mil. The current Total Equity is NT$5,443 Mil. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Total Equity is NT$5,443 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score

Get the complete analysis for TPE:7780

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.35
Price